Income Statement
IMPACT BIOMEDICAL INC.
IBO
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY |
|---|---|---|---|
|
Revenue
|
0.03 | - | - |
|
Cost of Revenue
|
0.42 | - | - |
|
Gross Profit
|
-0.39 | - | - |
|
Operating Expenses
|
4.31 | 28.75 | 1.46 |
|
Research & Development
|
0.34 | 0.28 | 1.15 |
|
Selling, General & Administrative
|
0.87 | 0.72 | 0.32 |
|
Other Operating Expenses
|
- | - | - |
|
Operating Income
|
-4.71 | -28.75 | -1.46 |
|
Non-Operating Income
|
9.74 | -4.02 | 2.95 |
|
Interest Income
|
- | - | 0.01 |
|
Interest Expense
|
0.79 | 1.07 | 0.44 |
|
Other Non-Op Income / Expense
|
- | - | - |
|
Income Before Tax
|
-14.45 | -24.74 | -4.41 |
|
Income Tax Expense
|
-2.61 | -0.03 | 0.00 |
|
Non-Controlling Interest
|
-0.03 | -0.06 | - |
|
Net Income
|
-11.84 | -24.71 | -4.41 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY |
|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - |
|
EBITDA
|
-3.56 | -27.63 | -0.34 |
|
Earnings Per Share (Basic)
|
-0.38 | -2.30 | -0.07 |
|
Diluted EPS
|
-0.38 | -2.30 | -0.07 |
|
Weighted Average Shares
|
31.55 | 10.76 | 60.25 |
|
Diluted Weighted Avg Shares
|
- | - | - |
|
Comprehensive Income
|
- | - | - |